Open AccessAnaphylactic shock secondary to teicoplanin
Author(s) -
Warrener Tim,
Southall Paul,
Kapur Sandeep
Publication year - 2014
Publication title -
anaesthesia cases
Language(s) - English
Resource type - Journals
ISSN - 2396-8397
DOI - 10.21466/ac.asstt2.2014
Subject(s) - teicoplanin , medicine , anaphylaxis , glycopeptide antibiotic , anaphylactic shock , shock (circulatory) , allergy , antibiotics , intensive care unit , glycopeptide , anesthesia , intensive care medicine , vancomycin , immunology , staphylococcus aureus , microbiology and biotechnology , biology , bacteria , genetics
Summary We describe a case of anaphylactic shock secondary to the glycopeptide antibiotic teicoplanin. A 35‐yr‐old female presented for a urological procedure due to complications following a previous gynaecological procedure. She reported an allergy to co‐amoxiclav and was therefore given teicoplanin as per our hospital protocol. This precipitated profound anaphylactic shock requiring admission to the intensive care unit. Subsequent immunological testing confirmed teicoplanin as the precipitant. Teicoplanin is only rarely associated with anaphylaxis, however it should be considered in patients suffering from a life‐threatening allergy.